Luckert, Claudia <br/><br/>
Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole.  [electronic resource] 

 -  Chemical research in toxicology  08 2018 
 - 784-798 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1520-5010 
<br/><br/><label>Standard No.: </label>10.1021/acs.chemrestox.8b00112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adverse Outcome Pathways<br/>Biological Assay<br/>Cell Line, Tumor<br/>Dose-Response Relationship, Drug<br/>Fatty Liver--chemically induced<br/>Fungicides, Industrial--toxicity<br/>Gene Expression<br/>HEK293 Cells<br/>Hepatocytes--drug effects<br/>Humans<br/>Mitochondria, Liver--drug effects<br/>Models, Biological<br/>Polymerase Chain Reaction<br/>Receptors, Cytoplasmic and Nuclear--metabolism<br/>Risk Assessment<br/>Triazoles--toxicity<br/>Triglycerides--metabolism